Modelling decay of population immunity with proposed second dose deferral strategy

J Graham - medRxiv, 2021 - medrxiv.org
A second dose deferred strategy has been proposed to increase initial population immunity
as an alternative to the default two dose vaccine regimen with spacing of 21 or 28 days …

The 2022 Aotearoa New Zealand National Seismic Hazard Model: Process, Overview, and Results

…, SM Ellis, J Fraser, K Graham… - Bulletin of the …, 2024 - pubs.geoscienceworld.org
The 2022 revision of Aotearoa New Zealand National Seismic Hazard Model (NZ NSHM 2022)
has involved significant revision of all datasets and model components. In this article, we …

[HTML][HTML] Phase III, randomized, double-blind, placebo-controlled evaluation of pregabalin for alleviating hot flashes, N07C1

…, KA Flynn, KM Rowland Jr, DL Graham… - Journal of clinical …, 2010 - ncbi.nlm.nih.gov
Purpose Hot flashes are a common problem for which effective and safe treatments are
needed. The current trial was conducted on the basis of preliminary promising data that …

Low Dose Regimens of BNT162b2 mRNA Vaccine Exceed SARS-Cov-2 Correlate of Protection Estimates for Symptomatic Infection, in those 19-55 Years of Age

G Jurgens - medRxiv, 2021 - medrxiv.org
Background An exact correlate of protection (CoP) is not yet known for symptomatic COVID-19.
However, it is still possible to show a new vaccine regimen exceeds an unknown CoP, …

Impact of standardized clinical assessment and management plans on resource utilization and costs in children after the arterial switch operation

…, AC Marshall, M Samnaliev, DA Graham… - Congenital Heart …, 2017 - Wiley Online Library
Background Standardized Clinical Assessment and Management Plans (SCAMPs) are a
quality improvement initiative designed to reduce unnecessary utilization, decrease practice …

Modelling Decay of Population Immunity With Proposed Second Dose Deferral Strategy (preprint)

GT Jurgens - 2021 - pesquisa.bvsalud.org
A second dose deferred strategy has been proposed to increase initial population immunity
as an alternative to the default two dose vaccine regimen with spacing of 21 or 28 days …

Modelled Optimization of SARS-Cov-2 Vaccine Distribution: an Evaluation of Second Dose Deferral Spacing of 6, 12, and 24 weeks (preprint)

G Jurgens, K Lackner - 2021 - pesquisa.bvsalud.org
Background: Multiple recent studies have shown strong first dose vaccine efficacy for both
Moderna mRNA-1273 and Pfizer/BioNTech BNT 162b2, which has stimulated discussion of …

Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck …

…, M Vosmik, M Andersen, N Gyldenkerne, H Jurgens… - The Lancet, 2019 - thelancet.com
Background Pembrolizumab is active in head and neck squamous cell carcinoma (HNSCC),
with programmed cell death ligand 1 (PD-L1) expression associated with improved …

Pregabalin for hot flashes in women: NCCTG trial N07C1

…, PJ Stella, KM Rowland Jr, DL Graham… - Journal of Clinical …, 2009 - ascopubs.org
9513 Background: Hot flashes are a major problem in many women for which better treatment
options are needed. Given the known efficacy of gabapentin for decreasing hot flashes, it …

[PDF][PDF] Season of Bison Mortality at the Jurgens Site, Weld County, Colorado

BW Schubert, JI Mead, RW Graham, TH Heaton… - researchgate.net
… whether more than one kill event is represented at Jurgens. … number of mortality events at
Jurgens or whether the bison … during the analysis of the Jurgens collection. Margaret Beck and …